Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Simple item page
dc.contributor.authorFaustino Torrico
dc.contributor.authorJoaquím Gascón
dc.contributor.authorLourdes Ortiz
dc.contributor.authorCristina Alonso‐Vega
dc.contributor.authorMaría‐Jesús Pinazo
dc.contributor.authorAlejandro G. Schijman
dc.contributor.authorIgor C. Almeida
dc.contributor.authorFabiana Alves
dc.contributor.authorNathalie Strub‐Wourgaft
dc.contributor.authorIsabela Ribeiro
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:51:00Z
dc.date.available2026-03-22T13:51:00Z
dc.date.issued2018
dc.descriptionCitaciones: 292
dc.identifier.doi10.1016/s1473-3099(17)30538-8
dc.identifier.urihttps://doi.org/10.1016/s1473-3099(17)30538-8
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43080
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofThe Lancet Infectious Diseases
dc.sourceFundación PROINPA
dc.subjectBenznidazole
dc.subjectPlacebo
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectClinical endpoint
dc.subjectPopulation
dc.subjectChagas disease
dc.subjectAdverse effect
dc.subjectRash
dc.subjectClinical trial
dc.titleTreatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
dc.typearticle

Files

Collections

Artículo Científico Publicado